BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15732133)

  • 1. Protein chip-based microarray profiling of oxidized low density lipoprotein-treated cells.
    Sukhanov S; Delafontaine P
    Proteomics; 2005 Apr; 5(5):1274-80. PubMed ID: 15732133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global analysis of differentially expressed genes in oxidized LDL-treated human aortic smooth muscle cells.
    Sukhanov S; Hua Song Y; Delafontaine P
    Biochem Biophys Res Commun; 2003 Jun; 306(2):443-9. PubMed ID: 12804583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oxidized low-density lipoprotein on the expression of the prorenin receptor in human aortic smooth muscle cells.
    Cheng Y; Liu X; Zhang L; Zhang Y; Liu Y; Lu Y; Jiang Y
    Mol Med Rep; 2015 Jun; 11(6):4341-4. PubMed ID: 25626130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized LDL enhances stretch-induced smooth muscle cell proliferation through alterations in nuclear protein import.
    Chahine MN; Dibrov E; Blackwood DP; Pierce GN
    Can J Physiol Pharmacol; 2012 Dec; 90(12):1559-68. PubMed ID: 23210434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.
    Kiyan Y; Tkachuk S; Hilfiker-Kleiner D; Haller H; Fuhrman B; Dumler I
    J Mol Cell Cardiol; 2014 Jan; 66():72-82. PubMed ID: 24239845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells.
    Mattaliano MD; Huard C; Cao W; Hill AA; Zhong W; Martinez RV; Harnish DC; Paulsen JE; Shih HH
    Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1329-37. PubMed ID: 19279231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low-density lipoprotein increases bone sialoprotein expression in vascular smooth muscle cells via runt-related transcription factor 2.
    Farrokhi E; Samani KG; Chaleshtori MH
    Am J Med Sci; 2015 Mar; 349(3):240-3. PubMed ID: 25504218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
    Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
    J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel effect of oxidized low-density lipoprotein: cellular ATP depletion via downregulation of glyceraldehyde-3-phosphate dehydrogenase.
    Sukhanov S; Higashi Y; Shai SY; Itabe H; Ono K; Parthasarathy S; Delafontaine P
    Circ Res; 2006 Jul; 99(2):191-200. PubMed ID: 16778134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptor.
    Higashi Y; Peng T; Du J; Sukhanov S; Li Y; Itabe H; Parthasarathy S; Delafontaine P
    J Lipid Res; 2005 Jun; 46(6):1266-77. PubMed ID: 15805544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases.
    Chen KC; Wang YS; Hu CY; Chang WC; Liao YC; Dai CY; Juo SH
    FASEB J; 2011 May; 25(5):1718-28. PubMed ID: 21266537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperoside inhibits the effects induced by oxidized low-density lipoprotein in vascular smooth muscle cells via oxLDL-LOX-1-ERK pathway.
    Zhang Z; Zhang D; Du B; Chen Z
    Mol Cell Biochem; 2017 Sep; 433(1-2):169-176. PubMed ID: 28434118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Trained Innate Immunity in oxLDL Primed Human Coronary Smooth Muscle Cells.
    Schnack L; Sohrabi Y; Lagache SMM; Kahles F; Bruemmer D; Waltenberger J; Findeisen HM
    Front Immunol; 2019; 10():13. PubMed ID: 30728822
    [No Abstract]   [Full Text] [Related]  

  • 14. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
    Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of MIF expression by oxidized LDL via activation of NF-kappaB in vascular smooth muscle cells.
    Chen L; Yang G; Zhang X; Wu J; Gu Q; Wei M; Yang J; Zhu Y; Wang N; Guan Y
    Atherosclerosis; 2009 Dec; 207(2):428-33. PubMed ID: 19640536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFalpha-NFkappaB-dependent manner.
    Barlic J; Zhang Y; Murphy PM
    J Biol Chem; 2007 Jun; 282(26):19167-76. PubMed ID: 17456471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment.
    Keiper T; Al-Fakhri N; Chavakis E; Athanasopoulos AN; Isermann B; Herzog S; Saffrich R; Hersemeyer K; Bohle RM; Haendeler J; Preissner KT; Santoso S; Chavakis T
    FASEB J; 2005 Dec; 19(14):2078-80. PubMed ID: 16195363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized low-density lipoprotein promotes osteoblast differentiation in primary cultures of vascular smooth muscle cells by up-regulating Osterix expression in an Msx2-dependent manner.
    Taylor J; Butcher M; Zeadin M; Politano A; Shaughnessy SG
    J Cell Biochem; 2011 Feb; 112(2):581-8. PubMed ID: 21268079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin.
    Liu J; Ren Y; Kang L; Zhang L
    Int J Mol Med; 2014 May; 33(5):1341-7. PubMed ID: 24590381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized LDL promotes the mitogenic actions of Chlamydia pneumoniae in vascular smooth muscle cells.
    Chahine MN; Deniset J; Dibrov E; Hirono S; Blackwood DP; Austria JA; Pierce GN
    Cardiovasc Res; 2011 Dec; 92(3):476-83. PubMed ID: 22072707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.